Table. Seroprevalence of IgG antibody against norovirus GIV.1 and GIV.2 in human serum specimens, Italy, 2010–2011*.
NoV GIV virus-like particles |
Serum dilutions |
Total (%) |
|
1:200 (%) |
1:400 (%) |
||
GIV.1 | 78 (14.5) | 40 (7.4) | 118/535 (22.0) |
GIV.2 | 12 (2.2) | 14 (2.6) | 26/535 (4.8) |
GIV.1+GIV.2 | 3 (0.5) | 4 (0.7) | 7/535 (1.3) |
*GIV; genogroup IV; NoV, norovirus.